Cargando…

3199 Effect of OSAS on Insulin Sensitivity and Cardiovascular Risk in PCOS Adolescents

OBJECTIVES/SPECIFIC AIMS: This study seeks to evaluate the role of PCOS in insulin resistance and sleep apnea in adolescents. METHODS/STUDY POPULATION: 37 adolescent patients 13-21 with PCOS (27 obese, 11 lean), along with 8 controls ages 18-21 were recruited. Subjects underwent a hyperinsulinemic e...

Descripción completa

Detalles Bibliográficos
Autores principales: Underland, Lisa, Kenigsberg, Lisa, Arens, Ranaan, Heptulla, Rubina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6799495/
http://dx.doi.org/10.1017/cts.2019.96
_version_ 1783460297603809280
author Underland, Lisa
Kenigsberg, Lisa
Arens, Ranaan
Heptulla, Rubina
author_facet Underland, Lisa
Kenigsberg, Lisa
Arens, Ranaan
Heptulla, Rubina
author_sort Underland, Lisa
collection PubMed
description OBJECTIVES/SPECIFIC AIMS: This study seeks to evaluate the role of PCOS in insulin resistance and sleep apnea in adolescents. METHODS/STUDY POPULATION: 37 adolescent patients 13-21 with PCOS (27 obese, 11 lean), along with 8 controls ages 18-21 were recruited. Subjects underwent a hyperinsulinemic euglycemic clamp study and a proportion of the PCOS subjects also underwent polysomnography. Baseline parameters were compared and M/I (index of insulin sensitivity), and GIR were compared. RESULTS/ANTICIPATED RESULTS: M/I was only statistically significantly different between obese PCOS subjects vs control (0.056 vs 0.17, p=0.0061). GIR was higher in the obese PCOS group compared to the lean PCOS group (2.48 vs 6.79, p=0.0001). There were no differences in GIR between the lean PCOS subjects and control (6.79 vs 9.08, p=0.30). 21 obese PCOS subjects and 10 lean PCOS underwent polysomnography. None of the lean PCOS subjects had obstructive sleep apnea (OSA). 8 of the obese subjects had OSA. DISCUSSION/SIGNIFICANCE OF IMPACT: More studies are needed to assess insulin sensitivity and sleep apnea in adolescents with lean PCOS. Our study did not find more insulin resistance in adolescents with PCOS compared to lean controls apart from what would be expected from obesity. Of adolescent obese subjects with PCOS, OSA seems quite prevalent and providers should consider screening and referral for these patients.
format Online
Article
Text
id pubmed-6799495
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-67994952019-10-28 3199 Effect of OSAS on Insulin Sensitivity and Cardiovascular Risk in PCOS Adolescents Underland, Lisa Kenigsberg, Lisa Arens, Ranaan Heptulla, Rubina J Clin Transl Sci Clinical Epidemiology/Clinical Trial OBJECTIVES/SPECIFIC AIMS: This study seeks to evaluate the role of PCOS in insulin resistance and sleep apnea in adolescents. METHODS/STUDY POPULATION: 37 adolescent patients 13-21 with PCOS (27 obese, 11 lean), along with 8 controls ages 18-21 were recruited. Subjects underwent a hyperinsulinemic euglycemic clamp study and a proportion of the PCOS subjects also underwent polysomnography. Baseline parameters were compared and M/I (index of insulin sensitivity), and GIR were compared. RESULTS/ANTICIPATED RESULTS: M/I was only statistically significantly different between obese PCOS subjects vs control (0.056 vs 0.17, p=0.0061). GIR was higher in the obese PCOS group compared to the lean PCOS group (2.48 vs 6.79, p=0.0001). There were no differences in GIR between the lean PCOS subjects and control (6.79 vs 9.08, p=0.30). 21 obese PCOS subjects and 10 lean PCOS underwent polysomnography. None of the lean PCOS subjects had obstructive sleep apnea (OSA). 8 of the obese subjects had OSA. DISCUSSION/SIGNIFICANCE OF IMPACT: More studies are needed to assess insulin sensitivity and sleep apnea in adolescents with lean PCOS. Our study did not find more insulin resistance in adolescents with PCOS compared to lean controls apart from what would be expected from obesity. Of adolescent obese subjects with PCOS, OSA seems quite prevalent and providers should consider screening and referral for these patients. Cambridge University Press 2019-03-27 /pmc/articles/PMC6799495/ http://dx.doi.org/10.1017/cts.2019.96 Text en © The Association for Clinical and Translational Science 2019 http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article, distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives licence (http://creativecommons.org/licenses/by-ncnd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is unaltered and is properly cited. The written permission of Cambridge University Press must be obtained for commercial re-use or in order to create a derivative work.
spellingShingle Clinical Epidemiology/Clinical Trial
Underland, Lisa
Kenigsberg, Lisa
Arens, Ranaan
Heptulla, Rubina
3199 Effect of OSAS on Insulin Sensitivity and Cardiovascular Risk in PCOS Adolescents
title 3199 Effect of OSAS on Insulin Sensitivity and Cardiovascular Risk in PCOS Adolescents
title_full 3199 Effect of OSAS on Insulin Sensitivity and Cardiovascular Risk in PCOS Adolescents
title_fullStr 3199 Effect of OSAS on Insulin Sensitivity and Cardiovascular Risk in PCOS Adolescents
title_full_unstemmed 3199 Effect of OSAS on Insulin Sensitivity and Cardiovascular Risk in PCOS Adolescents
title_short 3199 Effect of OSAS on Insulin Sensitivity and Cardiovascular Risk in PCOS Adolescents
title_sort 3199 effect of osas on insulin sensitivity and cardiovascular risk in pcos adolescents
topic Clinical Epidemiology/Clinical Trial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6799495/
http://dx.doi.org/10.1017/cts.2019.96
work_keys_str_mv AT underlandlisa 3199effectofosasoninsulinsensitivityandcardiovascularriskinpcosadolescents
AT kenigsberglisa 3199effectofosasoninsulinsensitivityandcardiovascularriskinpcosadolescents
AT arensranaan 3199effectofosasoninsulinsensitivityandcardiovascularriskinpcosadolescents
AT heptullarubina 3199effectofosasoninsulinsensitivityandcardiovascularriskinpcosadolescents